Lesinurad for treatment of hyperuricemia associated with gout, in combination with a xanthine oxidase inhibitor
The US Food and Drug Administration’s ( FDA ) Arthritis Advisory Committee ( AAC ) voted 10 to 4 to recommend the approval of Lesinurad 200mg tablets for the treatment of hyperuricemia associated with ...
read article